Related Experiment Video
Updated: Apr 15, 2026

08:47
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
3.2K
Computer-assisted staging of chronic rhinosinusitis correlates with symptoms
Jonathan Garneau1, Michael Ramirez1, Samuel G Armato2
1Pritzker School of Medicine, The University of Chicago.
International Forum of Allergy & Rhinology
|April 10, 2015
Summary
A new Modified Lund Mackay (MLM) system for chronic rhinosinusitis (CRS) shows promise. This 3D imaging method correlates sinonasal inflammation with patient symptom burden, unlike older systems.
Area of Science:
- Medical imaging analysis
- Rhinology
- Chronic rhinosinusitis (CRS) research
Background:
- The current Lund-Mackay (LM) staging system for CRS has limitations in correlating with clinical parameters due to its coarse scale.
- A novel "Modified Lund Mackay" (MLM) system was developed using a 3D computerized method to quantify sinonasal mucosal inflammation volume.
Purpose of the Study:
- To determine if the MLM system correlates with patient symptoms and disease-specific quality of life.
- To compare the MLM system with the traditional LM staging system.
Main Methods:
- Collected Total Nasal Symptom Score (TNSS) and 22-item Sino-Nasal Outcome Test (SNOT-22) data from 55 adult subjects.
- Quantified sinonasal mucosal inflammation volume using MATLAB algorithms and custom image analysis software.
- Employed linear regression and Spearman's rank correlation to analyze relationships between scoring systems and clinical data.
Main Results:
- A higher symptom burden was significantly associated with increased sinonasal inflammation measured by the MLM (β = 0.453, p < 0.013), after adjusting for covariates.
- Significant differences were observed between the LM and MLM scores (p < 0.011), reflecting distinct scales.
- No significant association was found between the MLM and SNOT-22 scores.
Conclusions:
- The MLM system represents an advancement as an imaging-based scoring system that correlates with sinonasal symptoms.
- Further development, including automation and validation in larger cohorts, could establish the MLM as a valuable biomarker for CRS treatment and clinical trials.

